Follow
Sylvain Mareschal
Sylvain Mareschal
LYSARC
Verified email at lysarc.org - Homepage
Title
Cited by
Cited by
Year
Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study
S Dubois, PJ Viailly, S Mareschal, E Bohers, P Bertrand, P Ruminy, ...
Clinical cancer research 22 (12), 2919-2928, 2016
2392016
Molecular profile and FDG-PET/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma
AS Cottereau, H Lanic, S Mareschal, M Meignan, P Vera, H Tilly, F Jardin, ...
Clinical Cancer Research 22 (15), 3801-3809, 2016
1792016
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
H Lanic, J Kraut-Tauzia, R Modzelewski, F Clatot, S Mareschal, ...
Leukemia & lymphoma 55 (4), 817-823, 2014
1482014
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma
P Ruminy, P Etancelin, L Couronné, F Parmentier, V Rainville, ...
Leukemia 25 (4), 681-688, 2011
1322011
Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing
S Mareschal, A Pham-Ledard, PJ Viailly, S Dubois, P Bertrand, ...
Journal of Investigative Dermatology 137 (9), 1984-1994, 2017
1192017
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
V Camus, A Stamatoullas, S Mareschal, PJ Viailly, N Sarafan-Vasseur, ...
Haematologica 101 (9), 1094, 2016
1182016
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
S Mareschal, H Lanic, P Ruminy, C Bastard, H Tilly, F Jardin
Haematologica 96 (12), 1888, 2011
1142011
Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P–mutated diffuse large B-cell lymphoma: analysis of 361 cases
S Dubois, PJ Viailly, E Bohers, P Bertrand, P Ruminy, V Marchand, ...
Clinical Cancer Research 23 (9), 2232-2244, 2017
1112017
Targetable activating mutations are very frequent in GCB and ABC diffuse large B‐cell lymphoma
E Bohers, S Mareschal, A Bouzelfen, V Marchand, P Ruminy, ...
Genes, Chromosomes and Cancer 53 (2), 144-153, 2014
1032014
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma
F Jardin, A Pujals, L Pelletier, E Bohers, V Camus, S Mareschal, S Dubois, ...
American journal of hematology 91 (9), 923-930, 2016
1022016
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B‐cell lymphoma
S Mareschal, S Dubois, PJ Viailly, P Bertrand, E Bohers, C Maingonnat, ...
Genes, Chromosomes and Cancer 55 (3), 251-267, 2016
1022016
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma
M Fontanilles, F Marguet, É Bohers, PJ Viailly, S Dubois, P Bertrand, ...
Oncotarget 8 (29), 48157, 2017
1002017
EZH2 alterations in follicular lymphoma: biological and clinical correlations
S Huet, L Xerri, B Tesson, S Mareschal, S Taix, L Mescam-Mancini, ...
Blood cancer journal 7 (4), e555-e555, 2017
972017
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like …
E Bohers, PJ Viailly, S Dubois, P Bertrand, C Maingonnat, S Mareschal, ...
Haematologica 100 (7), e280, 2015
952015
Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma
V Camus, N Sarafan-Vasseur, E Bohers, S Dubois, S Mareschal, ...
Leukemia & lymphoma 57 (9), 2171-2179, 2016
932016
Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of …
A Stamatoullas, P Brice, R Bouabdallah, S Mareschal, V Camus, I Rahal, ...
British journal of haematology 170 (2), 179-184, 2015
842015
Accurate classification of germinal center B-cell–like/activated B-cell–like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase–multiplex ligation …
S Mareschal, P Ruminy, C Bagacean, V Marchand, M Cornic, JP Jais, ...
The Journal of Molecular Diagnostics 17 (3), 273-283, 2015
792015
Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study
V Bobée, P Ruminy, V Marchand, PJ Viailly, AA Sater, L Veresezan, ...
The Journal of Molecular Diagnostics 19 (6), 892-904, 2017
562017
Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell …
H Lanic, S Mareschal, F Mechken, JM Picquenot, M Cornic, C Maingonnat, ...
Leukemia & lymphoma 53 (1), 34-42, 2012
552012
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
S Dubois, S Mareschal, JM Picquenot, PJ Viailly, E Bohers, M Cornic, ...
Oncotarget 6 (18), 16712, 2015
432015
The system can't perform the operation now. Try again later.
Articles 1–20